Ekins, Sean
Collaborations Pharmaceuticals (United States)
18 papers on CoChatORCID 0000-0002-5691-5790
Most cited papers
- Verified
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials
Computational Drug Discovery MethodsMachine Learning in Materials Science
Cited by 578
- Verified
Dual use of artificial-intelligence-powered drug discovery
Urbina, F., Lentzos, F., Invernizzi, C., & Ekins, S. (2022) · Nature Machine Intelligence
Computational Drug Discovery MethodsLaw, AI, and Intellectual Property
Cited by 346
- Verified
Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction
Krasowski, M. D., Drees, D., Morris, C. S., Maakestad, J., Blau, J. L., & Ekins, S. (2014) · BMC Clinical Pathology
Clinical Laboratory Practices and Quality ControlAdrenal Hormones and Disorders
Cited by 212
- Verified
A critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews
Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Research
Cited by 206
- Verified
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Russo, D. P., Zorn, K. M., Clark, A. M., Zhu, H., & Ekins, S. (2018) · Molecular Pharmaceutics
Computational Drug Discovery MethodsMachine Learning in Materials Science
Cited by 152
- Verified
Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier
Yasuda, K., Cline, C., Vogel, P., Onciu, M., Fatima, S., Sorrentino, B. P., Thirumaran, R. K., Ekins, S., Urade, Y., Fujimori, K., et al. (2013) · Drug Metabolism and Disposition
Drug Transport and Resistance MechanismsBarrier Structure and Function Studies
Cited by 128
- Verified
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets
Clark, A. M., Dole, K., Coulon-Spektor, A., McNutt, A., Grass, G., Freundlich, J. S., Reynolds, R. C., & Ekins, S. (2015) · Journal of Chemical Information and Modeling
Computational Drug Discovery MethodsMachine Learning in Materials Science
Cited by 114
- Verified
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
Ekins, S., Lage de Siqueira-Neto, J., McCall, L.-I., Sarker, M., Yadav, M., Ponder, E. L., Kallel, E. A., Kellar, D., Chen, S., Arkin, M., et al. (2015) · PLOS Neglected Tropical Diseases
Computational Drug Discovery MethodsTrypanosoma species research and implications
Cited by 93
- Verified
The natural product eugenol is an inhibitor of the ebola virus in vitro
Lane, T., Anantpadma, M., Freundlich, J. S., Davey, R. A., Madrid, P. B., & Ekins, S. (2019) · Pharmaceutical Research
Viral Infections and Outbreaks ResearchMedicinal Plant Research
Cited by 88
- Verified
Machine learning models identify molecules active against the Ebola virus in vitro
Ekins, S., Freundlich, J. S., Clark, A. M., Anantpadma, M., Davey, R. A., & Madrid, P. (2015) · F1000Research
Computational Drug Discovery MethodsViral Infections and Outbreaks Research
Cited by 84
- Verified
Ten simple rules of live tweeting at scientific conferences.
Ekins, S., & Perlstein, E. O. (2014) · PLoS Computational Biology
Academic Publishing and Open AccessSocial Media in Health Education
Cited by 55
- Verified
Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads
Anantpadma, M., Lane, T., Zorn, K. M., Lingerfelt, M. A., Clark, A. M., Freundlich, J. S., Davey, R. A., Madrid, P. B., & Ekins, S. (2019) · ACS Omega
Computational Drug Discovery MethodsViral Infections and Outbreaks Research
Cited by 54
- Verified
Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data
Perryman, A. L., Stratton, T. P., Ekins, S., & Freundlich, J. S. (2016) · Pharmaceutical Research
Computational Drug Discovery MethodsPharmacogenetics and Drug Metabolism
Cited by 50
- Verified
Machines first, humans second: on the importance of algorithmic interpretation of open chemistry data
Clark, A. M., Williams, A. J., & Ekins, S. (2015) · Journal of Cheminformatics
Research Data Management PracticesScientific Computing and Data Management
Cited by 33
- Verified
Naïve Bayesian Models for Vero Cell Cytotoxicity
Perryman, A. L., Patel, J. S., Russo, R., Singleton, E., Connell, N., Ekins, S., & Freundlich, J. S. (2018) · Pharmaceutical Research
Computational Drug Discovery MethodsMachine Learning in Materials Science
Cited by 33
- Verified
Industrializing rare disease therapy discovery and development
Ekins, S. (2017) · Nature Biotechnology
Genomics and Rare DiseasesScience, Research, and Medicine
Cited by 28
- Verified
Addressing the Metabolic Stability of Antituberculars through Machine Learning
Stratton, T. P., Perryman, A. L., Vilchèze, C., Russo, R., Li, S.-G., Patel, J. S., Singleton, E., Ekins, S., Connell, N., Jacobs, W. R., et al. (2017) · ACS Medicinal Chemistry Letters
Computational Drug Discovery MethodsPharmacogenetics and Drug Metabolism
Cited by 14
- Verified
Doing it All - How Families are Reshaping Rare Disease Research
Ekins, S., & Perlstein, E. O. (2018) · Pharmaceutical Research
Mental Health and Patient InvolvementBiomedical Ethics and Regulation
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free